From thrombolytic megatrials to clinical policy-making: facing the facts.
Publication
, Journal Article
Naylor, CD; Armstrong, PW
Published in: Can J Cardiol
June 1995
Duke Scholars
Published In
Can J Cardiol
ISSN
0828-282X
Publication Date
June 1995
Volume
11
Issue
6
Start / End Page
472 / 476
Location
England
Related Subject Headings
- United States
- Tissue Plasminogen Activator
- Thrombolytic Therapy
- Randomized Controlled Trials as Topic
- Myocardial Infarction
- Humans
- Guidelines as Topic
- Fibrinolytic Agents
- Drug Evaluation
- Clinical Trials as Topic
Citation
APA
Chicago
ICMJE
MLA
NLM
Naylor, C. D., & Armstrong, P. W. (1995). From thrombolytic megatrials to clinical policy-making: facing the facts. Can J Cardiol, 11(6), 472–476.
Naylor, C. D., and P. W. Armstrong. “From thrombolytic megatrials to clinical policy-making: facing the facts.” Can J Cardiol 11, no. 6 (June 1995): 472–76.
Naylor CD, Armstrong PW. From thrombolytic megatrials to clinical policy-making: facing the facts. Can J Cardiol. 1995 Jun;11(6):472–6.
Naylor, C. D., and P. W. Armstrong. “From thrombolytic megatrials to clinical policy-making: facing the facts.” Can J Cardiol, vol. 11, no. 6, June 1995, pp. 472–76.
Naylor CD, Armstrong PW. From thrombolytic megatrials to clinical policy-making: facing the facts. Can J Cardiol. 1995 Jun;11(6):472–476.
Published In
Can J Cardiol
ISSN
0828-282X
Publication Date
June 1995
Volume
11
Issue
6
Start / End Page
472 / 476
Location
England
Related Subject Headings
- United States
- Tissue Plasminogen Activator
- Thrombolytic Therapy
- Randomized Controlled Trials as Topic
- Myocardial Infarction
- Humans
- Guidelines as Topic
- Fibrinolytic Agents
- Drug Evaluation
- Clinical Trials as Topic